Pharmaceutical Substances - Version 4.1
The version 4.1 of Pharmaceutical Substances was launched in October 2016.
Pharmaceutical Substances 4.1 contains 17 new APIs and a total of 37,131 structures, 11,574 reactions and 2,641 active pharmaceutical ingredients.
New APIs
- Suvorexant
- Fusidic Acid
- Teicoplanin (update)
- Cangrelor
- Nilotinib (update)
- Netupitant
- Rolapitant
- Tipiracil
- Anidulafungin
- Ospemifene
- Alectinib
- Lesinurad
- Ixazomib Citrate
- Cobimetinib
- Selexipag
- Apatinib
- Osimertinib
“Anticancers are still the main focus of drug development. This is reflected also in the approval practice of FDA and EMA within the last 5 years with a relatively high share of new anticancer drugs. As a consequence, the new update with in total 17 monographs contains 7 recently approved anticancers, and 5 of them are protein kinase inhibitors.”
Prof. Axel Kleemann, Author
Contact
Thieme Chemistry Marketing Phone:+49-711-89310 E-Mail
